Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Clinical trial NCT02016690 · COMPLETED

Trial details

NCT number: NCT02016690
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Syncytial Virus Infection

Start date: 2013-12-01
Primary completion: 2015-12-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.